InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (9 ops.)
Insider track record
CFODisclosed buys
3
Disclosed sells
9
T+90 hit rate
0%
T+90 mean return
-14.5%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Mackaness James H, Chief Financial Officer. Director active across 1 company, notably Soleno Therapeutics INC. Aggregated, 20 filings have been logged. Split: 3 buys · 9 sells. Total volume traded: €1.3m. History available since 13 September 2021. The latest transaction was filed on 21 January 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Mackaness James H
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
28,600 shares0Common StockSEC:0001422484-26-000001:0
2,013 shares@ US$49.956.0% of flowCommon StockSEC:0001422484-25-000003:0
1,669 shares@ US$65.96917.6% of flowCommon StockSEC:0001415889-25-009295:0
14,500 shares0Common StockSEC:0001415889-25-001935:0
3,762 shares@ US$45.365612.2% of flowCommon StockSEC:0001415889-25-000955:0
7,248 shares@ US$49.335823.9% of flowCommon StockSEC:0001415889-24-024664:0
3,561 shares@ US$47.192611.2% of flowCommon StockSEC:0001415889-24-022650:0
3,858 shares@ US$45.476711.9% of flowCommon StockSEC:0001415889-24-020945:0
100,000 shares0Common StockSEC:0001415889-24-019808:0
1,568 shares@ US$41.22174.5% of flowCommon StockSEC:0001415889-24-019269:0
3,104 shares@ US$41.12278.8% of flowCommon StockSEC:0001415889-24-010247:0
56,000 shares0Common StockSEC:0001209191-24-001176:0
2,666 shares@ US$4.500.8% of flowCommon StockSEC:0001209191-23-058574:0
15,000 shares@ US$2.5952.7% of flowCommon StockSEC:0001209191-23-058576:0
4,186 shares@ US$28.65198.1% of flowCommon StockSEC:0001209191-23-057320:0
3,205 shares@ US$27.02625.8% of flowCommon StockSEC:0001209191-23-057036:0
29,084 shares0Common StockSEC:0001209191-23-032694:0
40,000 sharesCommon StockSEC:0000899243-22-013308:0
Canonical exit: 29 Jun 2022 (T+90)
6,060 shares@ US$1.650.0003% mcap25.7% of flowCommon StockSEC:0000899243-21-035862:0
Canonical exit: 24 Sept 2020 (T+90)
11,235 shares@ US$0.88840.6% of flowCommon StockSEC:0000899243-21-035864:0
Canonical exit: 12 Dec 2021 (T+90)
20 of 20 declarations
About Mackaness James H
Mackaness James H is Chief Financial Officer at Soleno Therapeutics INC, listed on XNAS, and is associated with 20 filings in total. Across the 20 sampled filings between 2021-09-14 and 2026-01-23, buys total EUR 17360 and sells total EUR 1269251, with Cession as the modal transaction nature.
